RGC
ALXN
Roberts, Glore & Co’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,694
| Closed | -$679K | – | 205 |
|
|
2021
Q2 | $679K | Hold |
3,694
| – | – | 0.2% | 104 |
|
|
2021
Q1 | $565K | Hold |
3,694
| – | – | 0.18% | 115 |
|
|
2020
Q4 | $577K | Buy |
3,694
+65
| +2% | +$10.2K | 0.19% | 112 |
|
|
2020
Q3 | $415K | Buy |
3,629
+1,395
| +62% | +$160K | 0.15% | 127 |
|
|
2020
Q2 | $250K | Buy |
+2,234
| New | +$250K | 0.1% | 141 |
|
|
2020
Q1 | – | Sell |
-2,075
| Closed | -$224K | – | 184 |
|
|
2019
Q4 | $224K | Buy |
+2,075
| New | +$224K | 0.09% | 163 |
|